Ingrid Mayer

13PUBLICATIONS
185CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersTe kāwana ā-hapori, whakatau take hoki o te Māori (Māori community governance and decision making)Metabolic medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Mar 27, 2026
CSF1R Inhibition with Chemotherapy Relieves Systemic Immune Suppression in Patients with Metastatic Triple-Negative Breast Cancer and Boosts anti-PD-1 Efficacy in Transgenic Mammary Tumors.

Amanda Poissonnier, Hope S Rugo, Wesley Horton

|Mar 10, 2026
The Pathologic Response Evaluation and Detection in Circulating Tumor-DNA Study: Ultrasensitive Circulating Tumor-DNA Assessment of Breast Cancer Minimal Residual Disease.

Natasha B Hunter, Heather A Parsons, Leslie Cope

|Jul 08, 2025
Phase Ib Trial of Fulvestrant, Palbociclib, and Erdafitinib, a pan-FGFR Tyrosine Kinase Inhibitor, in HR+/HER2- Metastatic Breast Cancer.

Paula I Gonzalez-Ericsson, Nisha Unni, Komal Jhaveri

|Sep 11, 2023
Effect of Metformin Versus Placebo on New Primary Cancers in Canadian Cancer Trials Group MA.32: A Secondary Analysis of a Phase III Randomized Double-Blind Trial in Early Breast Cancer.

Pamela J Goodwin, Bingshu E Chen, Karen A Gelmon

|Jul 14, 2023
Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor-Positive Breast Cancer.

Francisco Hermida-Prado, Yingtian Xie, Shira Sherman

|Jul 06, 2023
Cigarette and Alternative Tobacco Product Use among Adult Cancer Survivors Enrolled in 9 ECOG-ACRIN Clinical Trials.

Joanna M Streck, Ju-Whei Lee, Angela Wangari Walter

Pageof 3

Frequent Collaborators

5 joint publications

Angela M DeMichele

5 joint publications

Erica L Mayer

4 joint publications

Antonio C Wolff

4 joint publications

Ben Park